Pattern of Use of Bevacizumab or Cetuximab + FOLFIRI Regimen as First-line Treatment in Metastatic Colorectal Cancer
Clinical trial NCT03286738 · UNKNOWN
Trial details
- NCT number
- NCT03286738
- Sponsor
- Joong Bae Ahn
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2015-11-01
- Primary completion
- 2021-12-01
- Enrollment
- 1800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.